000			02349 a2200649 4500
005			20250513222347.0
264		0	_c20001205
008			200012s 0 0 eng d
022			_a1019-6439
024	7		_a10.3892/ijo.17.5.991 _2doi
040			_aNLM _beng _cNLM
100	1		_aToma, S
245	0	0	_aBiological activity of all-trans-retinoic acid with and without tamoxifen and alpha-interferon 2a in breast cancer patients. _h[electronic resource]
260			_bInternational journal of oncology _cNov 2000
300			_a991-1000 p. _bdigital
500			_aPublication Type: Clinical Trial; Clinical Trial, Phase I; Comparative Study; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
650	0	4	_aAged
650	0	4	_aAneuploidy
650	0	4	_aAntineoplastic Agents _xadverse effects
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xadverse effects
650	0	4	_aArea Under Curve
650	0	4	_aBone Marrow Diseases _xchemically induced
650	0	4	_aBreast Neoplasms _xchemistry
650	0	4	_aCarcinoma _xchemistry
650	0	4	_aDrug Administration Schedule
650	0	4	_aDrug Interactions
650	0	4	_aFemale
650	0	4	_aFollow-Up Studies
650	0	4	_aHeadache _xchemically induced
650	0	4	_aHumans
650	0	4	_aHypercholesterolemia _xchemically induced
650	0	4	_aInterferon alpha-2
650	0	4	_aInterferon-alpha _xadministration & dosage
650	0	4	_aKi-67 Antigen _xanalysis
650	0	4	_aMastectomy
650	0	4	_aMiddle Aged
650	0	4	_aNeoplasm Proteins _xanalysis
650	0	4	_aReceptors, Retinoic Acid _xanalysis
650	0	4	_aReceptors, Steroid _xanalysis
650	0	4	_aRecombinant Proteins
650	0	4	_aSafety
650	0	4	_aTamoxifen _xadministration & dosage
650	0	4	_aTransforming Growth Factor beta _xanalysis
650	0	4	_aTransforming Growth Factor beta1
650	0	4	_aTreatment Outcome
650	0	4	_aTretinoin _xadministration & dosage
700	1		_aRaffo, P
700	1		_aNicolo, G
700	1		_aCanavese, G
700	1		_aMargallo, E
700	1		_aVecchio, C
700	1		_aDastoli, G
700	1		_aIacona, I
700	1		_aRegazzi-Bonora, M
773	0		_tInternational journal of oncology _gvol. 17 _gno. 5 _gp. 991-1000
856	4	0	_uhttps://doi.org/10.3892/ijo.17.5.991 _zAvailable from publisher's website
999			_c10974608 _d10974608